Earnings History in Million
| Quarter ending 06/29/19 | |
|---|---|
| Estimated | 11.120 CHF |
| Actual | 11.120 CHF |
| Difference | - |
| Surprise | - |
Revenue History in Million
| Quarter ending 06/29/20 | Quarter ending 03/30/20 | Quarter ending 12/30/19 | Quarter ending 09/29/19 | Quarter ending 06/29/19 | |
|---|---|---|---|---|---|
| Estimated | 15,730 CHF | 15,060 CHF | 16,112 CHF | 15,597 CHF | 15,643 CHF |
| Actual | - | 15,143 CHF | 15,400 CHF | 15,597 CHF | 15,643 CHF |
| Difference | - | 83.000 | -711.868 | - | - |
| Surprise | - | 0.551 % | -4.418 % | - | - |
Estimates* for Roche AG (Genussschein) in CHF
| 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|
| Revenue | 64,134 | 65,614 | 67,051 | 69,997 |
| Dividend | 9.64 | 10.01 | 11.13 | 10.89 |
| Dividend Yield (in %) | - | - | - | - |
| EPS | 20.56 | 21.55 | 22.91 | 24.07 |
| P/E Ratio | - | - | - | - |
| EBIT | 23,157 | 24,164 | 25,346 | 26,999 |
| EBITDA | 25,740 | 26,740 | 27,506 | 29,476 |
| Net Profit | 16,021 | 16,853 | 17,828 | 19,932 |
| Net Profit Adjusted | 17,750 | 18,544 | 19,346 | 20,622 |
| Pre-Tax Profit | 22,545 | 24,092 | 23,534 | 26,485 |
| Net Profit (Adjusted) | 21,503 | 22,711 | 23,403 | 24,171 |
| EPS (Non-GAAP) ex. SOE | - | - | - | - |
| EPS (GAAP) | 17.43 | 18.29 | 19.53 | 21.83 |
| Gross Income | 47,452 | 48,972 | 50,739 | 53,097 |
| Cash Flow from Investing | -5,108 | -5,127 | -5,364 | -5,130 |
| Cash Flow from Operations | 21,013 | 21,792 | 21,040 | 23,302 |
| Cash Flow from Financing | -9,499 | -10,777 | -10,127 | -10,702 |
| Cash Flow per Share | 23.97 | 25.64 | 24.42 | 27.75 |
| Free Cash Flow | 15,795 | 16,568 | 15,989 | 18,221 |
| Free Cash Flow per Share | 18.21 | 19.02 | 17.66 | 22.33 |
| Book Value per Share | 48.51 | 57.12 | 63.00 | 78.20 |
| Net Debt | -2,069 | -8,398 | -10,079 | -20,552 |
| Research & Development Exp. | 12,313 | 12,569 | 12,510 | 12,609 |
| Capital Expenditure | 4,429 | 4,474 | 4,721 | 5,135 |
| Selling, General & Admin. Exp. | 16,228 | 16,814 | 13,400 | 13,815 |
| Shareholder’s Equity | 41,481 | 48,481 | 55,450 | 69,381 |
| Total Assets | 90,817 | 96,703 | 101,421 | 116,093 |
* Average Estimates in Million (e.g. Revenue) or per share (e.g. Dividend). Source: FactSet
Profit per share - Roche
| 13.2 13 | 11.0 14 | 10.4 15 | 11.2 16 | 10.1 17 | 12.3 18 | 15.8 19 |
Sales per share - Roche
| 54.2 13 | 55.0 14 | 55.9 15 | 58.8 16 | 62.0 17 | 66.1 18 | 71.1 19 |
P/E ratio - Roche
| 18.9 13 | 24.6 14 | 26.5 15 | 20.7 16 | 24.4 17 | 19.8 18 | 19.9 19 |
Roche AG (Genussschein): Share Earnings Data (in CHF)
| 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | |
|---|---|---|---|---|---|---|---|
| Basic earnings per share | 13.16 | 10.99 | 10.41 | 11.24 | 10.12 | 12.30 | 15.77 |
| Diluted earnings per share | 12.93 | 10.81 | 10.28 | 11.13 | 10.04 | 12.21 | 15.62 |
| Dividend per share | 7.80 | 8.00 | 8.10 | 8.20 | 8.30 | 8.70 | 9.00 |
| Distribution of dividends | 2.00 | 45.00 | 2.00 | 2.00 | 2.00 | 2.00 | 3.00 |
Roche AG (Genussschein): Key Data (in CHF)
| 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | |
|---|---|---|---|---|---|---|---|
| Sales per share | 54.21 | 55.00 | 55.85 | 58.81 | 61.98 | 66.10 | 71.14 |
| P/E ratio (year end quote, basic EPS) | 18.94 | 24.56 | 26.54 | 20.69 | 24.36 | 19.80 | 19.91 |
| P/E ratio (ear end quote, diluted EPS) | 19.27 | 24.97 | 26.89 | 20.90 | 24.55 | 19.94 | 20.10 |
| P/E ratio (year end quote) | 18.94 | 24.56 | 26.54 | 20.69 | 24.36 | 19.80 | 19.91 |
| Dividend yield in % | 3.13 | 2.96 | 2.93 | 3.53 | 3.37 | 3.57 | 2.87 |
| Equity ratio in % | 31.04 | 25.89 | 27.69 | 31.13 | 34.48 | 35.18 | 39.41 |
| Debt ratio in % | 65.83 | 71.50 | 69.25 | 65.63 | 62.17 | 61.33 | 56.83 |
Roche AG (Genussschein): Income statement (in MILLION CHF)
| 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | |
|---|---|---|---|---|---|---|---|
| Sales | 46,780 | 47,462 | 48,145 | 50,576 | 53,299 | 56,846 | 61,466 |
| Change of sales in % | 2.82 | 1.46 | 1.44 | 5.05 | 5.38 | 6.65 | 8.13 |
| Gross profit on sales | 33,856 | 34,531 | 33,937 | 35,594 | 37,448 | 40,209 | 43,804 |
| Gross profit on sales change in % | 0.93 | 1.99 | -1.72 | 4.88 | 5.21 | 7.37 | 8.94 |
| Operating income | 15,034 | 13,729 | 13,797 | 14,875 | 15,066 | 16,717 | 18,903 |
| Operating income change in % | 2.90 | -8.68 | 0.50 | 7.81 | 1.28 | 10.96 | 13.08 |
| Income before tax | 14,683 | 12,515 | 11,987 | 13,007 | 12,250 | 14,142 | 16,629 |
| Income before tax change in % | 19.15 | -14.77 | -4.22 | 8.51 | -5.82 | 15.44 | 17.59 |
| Income after tax | 11,164 | 9,332 | 8,863 | 9,576 | 8,633 | 10,500 | 13,497 |
| Income after tax change in % | 17.04 | -16.41 | -5.03 | 8.04 | -9.85 | 21.63 | 28.54 |
Roche AG (Genussschein): Balance (in MILLION CHF)
| 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | |
|---|---|---|---|---|---|---|---|
| Total liabilities | 40,926 | 54,083 | 52,463 | 50,417 | 47,669 | 48,151 | 47,224 |
| Total liabilities change in % | 29.64 | 36.45 | 33.68 | 32.65 | 29.88 | 29.40 | 27.00 |
| Equity | 21,241 | 21,558 | 23,300 | 26,402 | 29,007 | 30,366 | 35,867 |
| Equity change in % | 33.12 | 1.51 | 7.11 | 13.98 | 10.58 | 4.47 | 18.55 |
| Balance sheet total | 62,167 | 75,641 | 75,763 | 76,819 | 76,676 | 78,517 | 83,091 |
| Balance sheet total change in % | -4.07 | 21.67 | 0.16 | 1.39 | -0.19 | 2.40 | 5.83 |
Roche AG (Genussschein): Other data (in CHF)
| 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | |
|---|---|---|---|---|---|---|---|
| Profit per share (basic) | 13.16 | 10.99 | 10.41 | 11.24 | 10.12 | 12.30 | 15.77 |
| Profit per share (basic) change in % | 16.98 | -16.49 | -5.23 | 7.92 | -9.96 | 21.49 | 28.24 |
| Profit per share (diluted) | 12.93 | 10.81 | 10.28 | 11.13 | 10.04 | 12.21 | 15.62 |
| Profit per share (diluted) change in % | 15.86 | -16.40 | -4.90 | 8.27 | -9.79 | 21.59 | 27.94 |
| Number of employees | 85,080 | 88,509 | 91,747 | 94,052 | 93,734 | 94,442 | 97,735 |
| Number of employees change in % | 3.64 | 4.03 | 3.66 | 2.51 | -0.34 | 0.76 | 3.49 |
×
Added To Watchlist